Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study
Submitted by susan on Fri, 2015-09-04 11:57
Artemisinin-based combination therapies (ACTs) are the recommended first-line treatment for uncomplicated Plasmodium falciparum malaria. Ferroquine is a new combination partner for fast-acting ACTs such as artesunate. We aimed to assess different doses of ferroquine in combination with artesunate against uncomplicated P falciparum malaria in a heterogeneous population in Africa.
Mark Content Private(Internal):
External URL:
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(15)00079-1/abstract
Email Alert:
1-11
Publication Date:
02/09/2015